期刊文献+

妊娠滋养细胞肿瘤化疗进展 被引量:1

下载PDF
导出
摘要 妊娠滋养细胞肿瘤是一种可治愈的妇科肿瘤,化疗是妊娠滋养细胞肿瘤的首选治疗手段,但耐药成为治疗妊娠滋养细胞肿瘤的第一难题。因此,应根据疾病分型和患者病情,选择最佳的治疗方案,最大限度地降低耐药性和毒副作用的发生率,达到治愈目的。现通过复习国内外相关文献,综合论述目前妊娠滋养细胞肿瘤的化疗进展。
作者 曲波 王海琳
机构地区 甘肃省人民医院
出处 《卫生职业教育》 2015年第20期158-159,共2页 HEALTH VOCATIONAL EDUCATION
  • 相关文献

参考文献19

  • 1曹泽毅主编..中华妇产科学[M].北京:人民卫生出版社,2007:[19]图版).
  • 2Seckl M J,Sebire N J, Berkowitz R S. Gestational trophoblastic disease [j].Lancet, 2010(376): 717-729. 被引量:1
  • 3Feng F,Xiang Y,Wan X,et al.Salvage combination chemotherapy with floxuridine,dactinomycin,etoposide,and vincristine (FAEV)for patients with relapsed chemoresistant gestational trephoblastic neoplasia [J].Ann Oncol, 2011 (22) : 1588-1594. 被引量:1
  • 4Baptista A M,Belfort P. Comparison of methotrexate,actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia[J]. Int J Gynaecol Obstet,2012,119( 1 ) :35-38. 被引量:1
  • 5吴蕾..妊娠滋养细胞肿瘤的细胞增殖机制及化疗方案研究[D].北京协和医学院(清华大学医学部)&中国医学科学院,2013:
  • 6Alifrangis C, Agarwal R, Short D, et al. EMMCO for high-risk gestation- al trophoblastic neoplasia:good outcomes with induction low-dose etopo- side-cisplatin and genetic analysis[J].J Clin Oncol, 2013,31 ( 2 ) : 280-286. 被引量:1
  • 7Turan T,Karacay O, Tulunay G , et al. Results with EMA/CO ( E- toposide, Methotrexate, Actinomycin D , Cyclop hosphamide, Vin- cristine) Chemotherapy in Gestational Trophoblastic Neoplasia [J].Int J Gynecol Cancer, 2006, 16(3) : 1432-1438. 被引量:1
  • 8Kim S J,Bae S N, Kim J H, et al. Effects of muhiagent chemotherapy and independent risk factors in the treatment of high risk GTF- 25 years experiences of KRI-TRD[J] .IntJ Gynaecol Obstet, 1998,60( 11 ) : 85-96. 被引量:1
  • 9Rustin G J,Newlands E S, Lutz J M,et al.Combination but not Single-a- gent Methotrexate Chemotherapy for Gestational Trophoblastic Tumors In- creases the Incidence of Second Tumors [J],l Clin Oncol, 1996,14 (10) : 2769-2777. 被引量:1
  • 10Ghaemmaghami F,Modares M,Arab M,et aI.EMA-EP regimen,as firstline multiple agent chemotherapy in high-risk GTT patients (stage II -IV )[J].Int J Gyneco Cancer, 2004,14(2) : 360-367. 被引量:1

二级参考文献18

  • 1Lurain JR.Pharmacotherapy of gestational trophoblastic disease.Expert Opin Pharmacother,2003,4:2005-2017. 被引量:1
  • 2Lurain JR,Nejad B.Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.Gynecol Oncol,2005,97:618-623. 被引量:1
  • 3Pisal N,North C,Tidy J,et al.Role of hysterectomy in management of gestational trophoblastic disease.Gynecol Oncol,2002,87:190-192. 被引量:1
  • 4Ngu SF,Chan KKL.Management of chemoresistant and quiescent gestational trophoblastic disease EJI. Curr Obstet Gynecol Rep, 2014,3:84-90. 被引量:1
  • 5Meneish IA,Striekland S,Holden L,et al.Low-risk persistent ges- tational trophob|astic disease:outcome after initial treatment with low-dose methotrexate and folinie acid from 1992 to 2000[J]. J Clin 0ncol,2002,20:1838-1844. 被引量:1
  • 6Evan AC Jr,Schlaerh J,Gaddis O,et al.Gestational trophoblastic disease metastatic to the central nervous systenm [J].Gynecol 0nco1,1995,59:226-230. 被引量:1
  • 7Covens A,Filiaci VL,Burger RA,et al. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia:a Gynecologic Oncology Group study[J] .Cancer, 2006,107: 1280-1286. 被引量:1
  • 8Sarah N,Michael J,Seckl.Gestational trophoblastic neoplasia mangement:an update [ J ].Curr Opin 0ncol,2007,19:486-49 l. 被引量:1
  • 9Powles T, Savage PM,Stebbing J, et al. A comparison of patientswith relapsed and chemo-refractory gestational trophoblastic neoplasia [ J ]. Br J Cancer,2007,96(5):732-737. 被引量:1
  • 10Ngan HY, Kohorn EI, Cole LA, et al. Trophoblastic disease[J]. Int J Gynaecol Obstet,2012,119 Supp12:S130-136. 被引量:1

共引文献17

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部